Nuvectis Pharma Inc (NVCT) Insider Trading
Total insider buys:
- $4,352,163.92
Total insider sells:
- $0.00
Most recent insider trade:
- Dec. 24, 2024
Most active insider trader:
- Ron Bentsur
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 24, 2024 | CEO | 4,500 | $4.65 | Buy | $20,925.00 | |
Dec. 13, 2024 | Major Shareholder | 17,000 | $4.70 | Buy | $79,900.00 | |
Nov. 19, 2024 | Insider | 2,000 | $4.99 | Buy | $9,980.00 | |
Nov. 15, 2024 | CEO | 20,000 | $4.92 | Buy | $98,400.00 | |
May 14, 2024 | CEO | 1,940 | $6.74 | Buy | $13,075.60 | |
May 10, 2024 | Insider | 500 | $6.29 | Buy | $3,145.00 | |
May 10, 2024 | CEO | 2,000 | $6.40 | Buy | $12,800.00 | |
March 18, 2024 | CEO | 5,000 | $10.29 | Buy | $51,450.00 | |
Oct. 9, 2023 | CEO | 830 | $11.19 | Buy | $9,287.70 | |
Oct. 6, 2023 | CEO | 250 | $11.27 | Buy | $2,817.50 | |
Oct. 4, 2023 | CEO | 1,820 | $10.95 | Buy | $19,929.00 | |
Aug. 15, 2023 | CEO | 235 | $14.34 | Buy | $3,369.90 | |
Aug. 11, 2023 | CEO | 180 | $14.66 | Buy | $2,638.80 | |
Aug. 8, 2023 | CEO | 120 | $14.83 | Buy | $1,779.60 | |
July 31, 2023 | Major Shareholder | 860 | $13.88 | Buy | $11,936.80 | |
July 28, 2023 | Major Shareholder | 2,584 | $13.91 | Buy | $35,943.44 | |
July 26, 2023 | Major Shareholder | 10,000 | $13.97 | Buy | $139,700.00 | |
July 21, 2023 | CEO | 225 | $14.85 | Buy | $3,341.25 | |
July 20, 2023 | Major Shareholder | 5,394 | $14.40 | Buy | $77,673.60 | |
July 19, 2023 | CEO | 200 | $14.33 | Buy | $2,866.00 | |
July 18, 2023 | Major Shareholder | 9,149 | $14.84 | Buy | $135,771.16 | |
July 14, 2023 | CEO | 150 | $15.03 | Buy | $2,254.50 | |
July 11, 2023 | Major Shareholder | 10,000 | $15.36 | Buy | $153,600.00 | |
July 7, 2023 | Major Shareholder | 8,948 | $15.19 | Buy | $135,920.12 | |
July 6, 2023 | CEO | 320 | $14.88 | Buy | $4,761.60 | |
July 5, 2023 | Major Shareholder | 1,176 | $15.52 | Buy | $18,251.52 | |
June 26, 2023 | CEO | 750 | $16.50 | Buy | $12,375.00 | |
June 26, 2023 | Major Shareholder | 16,760 | $16.46 | Buy | $275,869.60 | |
June 23, 2023 | Major Shareholder | 73,175 | $17.43 | Buy | $1,275,440.25 | |
June 21, 2023 | Major Shareholder | 6,091 | $17.71 | Buy | $107,871.61 | |
June 21, 2023 | CEO | 500 | $17.88 | Buy | $8,940.00 | |
June 15, 2023 | Major Shareholder | 32,124 | $17.71 | Buy | $568,916.04 | |
June 7, 2023 | CEO | 230 | $17.41 | Buy | $4,004.30 | |
May 31, 2023 | CEO | 330 | $17.28 | Buy | $5,702.40 | |
May 24, 2023 | CEO | 200 | $17.49 | Buy | $3,498.00 | |
May 16, 2023 | CEO | 320 | $17.02 | Buy | $5,446.40 | |
March 27, 2023 | Insider | 500 | $11.55 | Buy | $5,775.00 | |
March 23, 2023 | CEO | 230 | $12.13 | Buy | $2,789.90 | |
March 21, 2023 | CEO | 480 | $12.08 | Buy | $5,798.40 | |
March 21, 2023 | Insider | 420 | $11.99 | Buy | $5,035.80 | |
March 15, 2023 | Insider | 670 | $10.71 | Buy | $7,175.70 | |
March 14, 2023 | CEO | 1,680 | $10.85 | Buy | $18,228.00 | |
Dec. 21, 2022 | Insider | 500 | $7.65 | Buy | $3,825.00 | |
Nov. 30, 2022 | CEO | 150 | $7.45 | Buy | $1,117.50 | |
Nov. 28, 2022 | CEO | 150 | $7.40 | Buy | $1,110.00 | |
Nov. 25, 2022 | CEO | 150 | $7.38 | Buy | $1,107.00 | |
Nov. 17, 2022 | CEO | 250 | $7.24 | Buy | $1,810.00 | |
Nov. 16, 2022 | Insider | 150 | $7.10 | Buy | $1,065.00 | |
Sept. 30, 2022 | CEO | 500 | $7.46 | Buy | $3,730.00 | |
Sept. 28, 2022 | CEO | 500 | $7.23 | Buy | $3,615.00 |
Insiders are buying Nuvectis Pharma Inc stock.
The insider traders at Nuvectis Pharma Inc are: Ron Bentsur, Marlio Charles Mosseri, Shay Shemesh, Enrique Poradosu, and Kenneth Hoberman
The most active insider trader at Nuvectis Pharma Inc is Ron Bentsur with 46 trades.
Marlio Charles Mosseri has bought the most Nuvectis Pharma Inc stock with a total value of $3,096,694.14.
The most recent insider trade for Nuvectis Pharma Inc was on Dec. 24, 2024.
The single biggest insider buy for Nuvectis Pharma Inc was from Marlio Charles Mosseri with a total value of $1,275,440.25 on June 23, 2023.